Can you share a case where topical therapies have failed to produce an acceptable clinical response, and in whom consideration of immunotherapy—including systemic treatment with dupilumab—would be indicated?

Can you share a case where topical therapies have failed to produce an acceptable clinical response, and in whom consideration of immunotherapy—including systemic treatment with dupilumab—would be indicated?

CLICK HERE FOR CME CREDIT Back to Symposium

Can you share a case where topical therapies have failed to produce an acceptable clinical response, and in whom consideration of immunotherapy—including systemic treatment with dupilumab—would be indicated? 

Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Peter Lio, MD

Peter Lio, MD

Clinical Assistant Professor of Dermatology and Pediatrics
Feinberg School of Medicine
Northwestern University
Chicago, Illinois